Clinical Trials Flashcards

1
Q

What to look for when looking at a clinical trial paper?

A
  • whether paper addresses your question
    -is study design appropriate for question asked
    -look at study subjects (how they are selected, what population, attention of individuals)
    -look at intervention and comparison
    -is placebo being used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

External validity

A

How applicable the results are to the general population of interest
**is the study population similar to the population you are comparing to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of control groups

A

1.Historical controls
2.Concurrent controls
3.Cross-over trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Concurrent control groups (parallel arm trials)

A

Control groups formed at the same time as the treatment group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Historical controls

A

Before and After groups

**less value because there are too many factors that can change over time causing differences between groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cross-over trials

A

utilize the same animals as treatment and control groups
»means that order of treatments must be randomized, and often need time period in between to was away any effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 Key elements of clinical trial design

A

1.Outcome measures
2. Bias
3. Chance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outcome measures

A

Check for:
-most clinically relevant
-easiest to measure reliably
-most objective outcome; subjective outcomes would need to be blind and have clear case definitions
-most specific (remove unrelated effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many outcomes involved in clinical trials?

A

-multiple outcomes is risky
-if you look at enough outcomes, one will likely be significant OR mistakes/false conclusions may be made
-author must prioritize them
-should focus on 1 or 2 primary outcome measures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of possible outcomes for BRD trial

A

-mortality (most objective)
-morbidity (need case definition)
-serological conversion (higher antibodies does not always mean immunity)
-Avg daily gain
-Feed efficiency (measured at pen level because can’t feed each individual alone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Experimental unit

A

-the smallest independent unit to which treatment is allocated

Examples: leg of animal, quarter of udder, individual animal, pen, herd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Feeding trial experimental unit

A

Pen=experimental unit

because can’t feed every individual separately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Herd immunity and its role in clinical trial

A

-vaccinated or treated animals may protect or reduce the challenge to all individuals in the herd or group altering the outcome/results making the differences in outcomes more similar

ex. anthelmintic trials or vaccine trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bias

A

-A factor (systemic) other than the treatment causes a difference in the outcome between the treatment and the control group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

4 key times when bias can occurs

A

1.Selection/randomization
2. Performance bias (cointervention)
3.Exclusion bias
4.Detection bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Selection/randomization causing bias

A

-systemic difference in the treatment and control groups attributable to lack of randomization

17
Q

Performance bias (cointervention)

A

Systemic differences in the care provided apart from the intervention being evaluated

18
Q

Exclusion bias

A

systemic differences in withdrawals from the trial

19
Q

Detection bias

A

-systemic differences in outcome assessment or follow-up

ex. detailed post mortem in treatment group but not the control group

20
Q

Sources of selection bias

A

1.Source Effect- both the treatment and control groups should be uniform. Cannot put all animals from one source into one group and all individuals from another source into another group

  1. Non-randomized clinical trials- self selected differences before intervention happens
21
Q

How to get rid of selection bias?

A

Randomization.
>baseline comparisons helps evaluate effectiveness of randomization

22
Q

Types of randomization

A
  1. Simple- toss a coin, random number tables/generator, Dice
  2. Systemic- not true randomization; randomize first animal and then alternate between groups
23
Q

Confounding variables

A
  • factors that may be related to the outcome measure that are not equally distributed between treatment and control groups
    -can lead to a difference in outcome that is not true
24
Q

How are confounding variables accounted for in a clinical trial?

A

-proper randomization should balance most confounding variables out EXCEPT in small trials

25
Q

Randomization

A

-produces comparable study groups
-removes investigator bias in participant allocation and guarantees statistical tests

26
Q

Stratification or blocking

A

-looks to solve confounding variables by dividing the population into different strata according to confounding variables and then use simple randomization in each subgroup

**important for small sizes

27
Q

Matching

A

-match individuals up based on similarity (age, breed, sex, time of admission) and then on individual is chosen to be control and one to be treatment

28
Q

Performance and exclusion bias

A

When treatment and control patients receive unequal observation, follow ups and ancillary treatments or their follow ups are lost

29
Q

Problems with ancillary treatment

A
  1. Contamination- control patients accidentally receive the experiment treatment
  2. Co-intervention- the performance of additional diagnostic or therapeutic acts on experimental but not control patients
30
Q

Detection bias

A

-bias occurring with diagnostic decisions because of knowledge of status OR because treatment and control groups process of measurement is different

extremely important in subjective measures

31
Q

Blinding

A

-Subject and observer are unaware of the treatment group to which subjects have been allocated

32
Q

Single blinding

A

-only subjects are unaware of which treatment group they are in
-needs to include a placebo

33
Q

Double blinding

A

both subjects and observers are unaware of treatment groups

34
Q

Triple blinding

A

subjects, observers, and statistical analysis is blinded

35
Q

What does blinding eliminate?

A

-performance bias
-exclusion bias
-detection bias